[HTML][HTML] Immune activated cellular therapy for drug resistant infections: rationale, mechanisms, and implications for veterinary medicine

LM Pezzanite, L Chow, A Strumpf, V Johnson… - Veterinary …, 2022 - mdpi.com
Simple Summary Mesenchymal stromal/stem cells have intrinsic antimicrobial properties,
thus making them attractive as an alternative treatment strategy in chronic, drug-resistant …

Integrin α10β1-selected mesenchymal stem cells mitigate the progression of osteoarthritis in an equine talar impact model

ML Delco, M Goodale, JF Talts… - … American Journal of …, 2020 - journals.sagepub.com
Background: Early intervention with mesenchymal stem cells (MSCs) after articular trauma
has the potential to limit progression of focal lesions and prevent ongoing cartilage …

The synthetic artificial stem cell (SASC): Shifting the paradigm of cell therapy in regenerative engineering

S Shah, CJ Esdaille, M Bhattacharjee… - Proceedings of the …, 2022 - National Acad Sciences
Stem cells are of great interest in tissue regeneration due to their ability to modulate the local
microenvironment by secreting bioactive factors (collectively, secretome). However …

[HTML][HTML] TLR-activated mesenchymal stromal cell therapy and antibiotics to treat multi-drug resistant Staphylococcal septic arthritis in an equine model

LM Pezzanite, L Chow, J Phillips… - Annals of …, 2022 - ncbi.nlm.nih.gov
Background Rapid development of antibiotic resistance necessitates advancement of novel
therapeutic strategies to treat infection. Mesenchymal stromal cells (MSC) possess …

[HTML][HTML] Pooled platelet-rich plasma lysate therapy increases synoviocyte proliferation and hyaluronic acid production while protecting chondrocytes from synoviocyte …

JM Gilbertie, JM Long, AG Schubert… - Frontiers in veterinary …, 2018 - frontiersin.org
Platelet-rich plasma (PRP) preparations are being used with moderate success to treat
osteoarthritis (OA) in humans and in veterinary species. Such preparations are hindered …

[HTML][HTML] Bone marrow MSC secretome increases equine articular chondrocyte collagen accumulation and their migratory capacities

R Contentin, M Jammes, B Bourdon, F Cassé… - International journal of …, 2022 - mdpi.com
Equine osteoarthritis (OA) leads to cartilage degradation with impaired animal well-being,
premature cessation of sport activity, and financial losses. Mesenchymal stem cell (MSC) …

[HTML][HTML] Gene therapy approaches for equine osteoarthritis

P Thampi, RJ Samulski, JC Grieger… - Frontiers in Veterinary …, 2022 - frontiersin.org
With an intrinsically low ability for self-repair, articular cartilage injuries often progress to
cartilage loss and joint degeneration resulting in osteoarthritis (OA). Osteoarthritis and the …

[HTML][HTML] Investigation of synovial fluid lubricants and inflammatory cytokines in the horse: a comparison of recombinant equine interleukin 1 beta-induced synovitis and …

A Watkins, D Fasanello, D Stefanovski, S Schurer… - BMC veterinary …, 2021 - Springer
Background Lameness is a debilitating condition in equine athletes that leads to more
performance limitation and loss of use than any other medical condition. There are a limited …

[HTML][HTML] Hyaluronic acid synthesis, degradation, and crosslinking in equine osteoarthritis: TNF-α-TSG-6-mediated HC-HA formation

DC Fasanello, J Su, S Deng, R Yin, MJ Colville… - Arthritis research & …, 2021 - Springer
Background TNF-α-stimulated gene 6 (TSG-6) protein, a TNF-α-responsive hyaladherin,
possesses enzymatic activity that can catalyze covalent crosslinks of the polysaccharide …

Intra-articular adeno-associated virus-mediated proteoglycan 4 gene therapy for preventing posttraumatic osteoarthritis

D Seol, HH Choe, H Zheng, MJ Brouillette… - Human gene …, 2022 - liebertpub.com
Lubricin, a glycoprotein encoded by the proteoglycan 4 (PRG4) gene, is an essential
boundary lubricant that reduces friction between articular cartilage surfaces. The loss of …